AIM ImmunoTech (AIM) Share-based Compensation (2011 - 2025)
AIM ImmunoTech (AIM) posted Share-based Compensation of $60,000 for FY2025, down 91.3% from $686,000 in FY2024.
Powered by 
Analysis
AIM ImmunoTech (AIM) Share-based Compensation (2011 - 2025) Analysis & Trends
Since FY2009, AIM ImmunoTech has reported Share-based Compensation for 17 years.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -43.4% (FY2020 to FY2025).
- The FY2025 figure stands as the lowest annual Share-based Compensation since FY2009.
- Business Quant data shows AIM's Share-based Compensation at $686,000 in FY2024 (+182.3%), $243,000 in FY2023 (-74.5%), $954,000 in FY2022 (-39.2%) and $1.57 million in FY2021 (+51.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 196,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 162,000.00 |
| Sep 30, 2022 | 275,000.00 |
| Jun 30, 2022 | 275,000.00 |
| Mar 31, 2022 | 242,000.00 |
| Dec 31, 2021 | 248,000.00 |
| Sep 30, 2021 | 314,000.00 |
| Jun 30, 2021 | 480,000.00 |
| Mar 31, 2021 | 526,000.00 |
| Dec 31, 2020 | 440,000.00 |
| Sep 30, 2020 | 250,000.00 |
| Jun 30, 2020 | 150,000.00 |
API Access
AIM ImmunoTech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();